These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2294778)

  • 21. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade metaplastic carcinomas of the thymus: biphasic thymic epithelial tumors with mesenchymal metaplasia--an update.
    Yoneda S; Marx A; Müller-Hermelink HK
    Pathol Res Pract; 1999; 195(8):555-63. PubMed ID: 10483586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
    Dorfman DM; Shahsafaei A; Miyauchi A
    Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic thymic carcinoma: a clinicopathologic and immunohistochemical study of 6 cases.
    Weissferdt A; Moran CA
    Hum Pathol; 2012 Jun; 43(6):874-7. PubMed ID: 22055398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathologic study of thymic epithelial tumors].
    Adachi K; Hosaka N; Takao M; Fujinaga K
    Kyobu Geka; 2005 Feb; 58(2):119-22. PubMed ID: 15724473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B; Rudnicka L; Dubiel-Bigaj M; Malinowski E
    Pol J Pathol; 1998; 49(4):251-65. PubMed ID: 10323079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopatholgical spectrum of thymic neoplasms: twelve-year experience at a referral hospital in north India.
    Radotra B; Awasthi A; Joshi K; Das A
    Indian J Pathol Microbiol; 2006 Jan; 49(1):1-6. PubMed ID: 16625962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
    Coyne JD; Dervan PA; Barr L
    Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of prognostic features in thymic epithelial tumors.
    Kirchner T; Schalke B; Marx A; Müller-Hermelink HK
    Thymus; 1989; 14(1-3):195-203. PubMed ID: 2623740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and immunohistochemical study of eight cases with thymic carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
    BMC Surg; 2002 May; 2():3. PubMed ID: 12049674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence.
    Marx A; Rieker R; Toker A; Länger F; Ströbel P
    Thorac Surg Clin; 2011 Feb; 21(1):25-31. v-vi. PubMed ID: 21070984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NUT midline carcinomas in the thymic region.
    Gökmen-Polar Y; Cano OD; Kesler KA; Loehrer PJ; Badve S
    Mod Pathol; 2014 Dec; 27(12):1649-56. PubMed ID: 24851833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.
    Kuo TT
    Histopathology; 2000 Jul; 37(1):19-26. PubMed ID: 10931214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of thymic carcinoma: analysis of 16 cases.
    Chang HK; Wang CH; Liaw CC; Ng KT; Chang JP; Chen MS; Kuo TT; Lai GM
    J Formos Med Assoc; 1992 Aug; 91(8):764-9. PubMed ID: 1362114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases.
    Kalhor N; Moran CA
    Hum Pathol; 2019 Jan; 83():100-105. PubMed ID: 30217623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sarcomatoid carcinoma of the thymus].
    Rogozhin DV; Konovalov DM; Andreeva MA; Samoĭlov DA; Kunitsin AG; Savkova RF; Konstantinova MM
    Arkh Patol; 2010; 72(2):34-5. PubMed ID: 20698314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Suster D; Pihan G; Mackinnon AC; Suster S
    Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.